Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127593851 | 12759385 | 1 | I | 20160908 | 20160919 | 20160919 | EXP | ES-HQ SPECIALTY-ES-2016INT000879 | INTERCHEM | FONTS N, MORENO ME, ANGUERA G, PALLARES MC, MANGUES MA.. SEVERE HEPATOTOXICITY IN A PATIENT TREATED WITH CHEMOTHERAPY AND PHYTOTHERAPY: A CASE REPORT. EUR J HOSP PHARM. 2014;21(1 SUPPL):A137 | 78.00 | YR | M | Y | 0.00000 | 20160919 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127593851 | 12759385 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | 175 M^2, DAY 1, 21-DAY CYCLES | 20262 | |||||||||||
| 127593851 | 12759385 | 2 | SS | ASCORBIC ACIDECHINACEAPROPOLIS WAX | ASCORBIC ACIDECHINACEAPROPOLIS WAX | 1 | Unknown | UNK | U | 0 | |||||||||
| 127593851 | 12759385 | 3 | SS | CARBOPLATIN AUC5 | CARBOPLATIN | 1 | UNK | 0 | |||||||||||
| 127593851 | 12759385 | 4 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | ||||||||
| 127593851 | 12759385 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | ||||||||
| 127593851 | 12759385 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | ||||||||
| 127593851 | 12759385 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127593851 | 12759385 | 1 | Lung adenocarcinoma stage IV |
| 127593851 | 12759385 | 2 | Dysphonia |
| 127593851 | 12759385 | 3 | Lung adenocarcinoma stage IV |
| 127593851 | 12759385 | 4 | Hypertension |
| 127593851 | 12759385 | 5 | Dyslipidaemia |
| 127593851 | 12759385 | 6 | Retinal vascular thrombosis |
| 127593851 | 12759385 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127593851 | 12759385 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127593851 | 12759385 | Drug interaction | |
| 127593851 | 12759385 | Hepatotoxicity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |